Is surgery always necessary in rectal cancer? (2014)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- Subjects: NEOPLASIAS RETAIS (CIRURGIA;QUIMIOTERAPIA); PROCEDIMENTOS CIRÚRGICOS OPERATÓRIOS; TERAPIA COMBINADA
- Language: Inglês
- Imprenta:
- Publisher place: Williston Park
- Date published: 2014
- Source:
- Título: Oncology
- Volume/Número/Paginação/Ano: v. 28, n. 7, p. 607-611, 2014
-
ABNT
SABBAGA, Jorge e BRAGHIROLI, Maria Ignez e HOFF, Paulo M. Is surgery always necessary in rectal cancer?. Oncology, v. 28, n. 7, p. 607-611, 2014Tradução . . Disponível em: http://www.cancernetwork.com/oncology-journal/surgery-always-necessary-rectal-cancer. Acesso em: 04 mar. 2026. -
APA
Sabbaga, J., Braghiroli, M. I., & Hoff, P. M. (2014). Is surgery always necessary in rectal cancer? Oncology, 28( 7), 607-611. Recuperado de http://www.cancernetwork.com/oncology-journal/surgery-always-necessary-rectal-cancer -
NLM
Sabbaga J, Braghiroli MI, Hoff PM. Is surgery always necessary in rectal cancer? [Internet]. Oncology. 2014 ; 28( 7): 607-611.[citado 2026 mar. 04 ] Available from: http://www.cancernetwork.com/oncology-journal/surgery-always-necessary-rectal-cancer -
Vancouver
Sabbaga J, Braghiroli MI, Hoff PM. Is surgery always necessary in rectal cancer? [Internet]. Oncology. 2014 ; 28( 7): 607-611.[citado 2026 mar. 04 ] Available from: http://www.cancernetwork.com/oncology-journal/surgery-always-necessary-rectal-cancer - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
